Lv1
40 积分 2021-03-14 加入
Antibodies to m‐type phospholipase A2 receptor in children with idiopathic membranous nephropathy
1个月前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
1个月前
已完结
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents
4个月前
已完结
Journey of B Cell Dysregulation in Rheumatoid Arthritis: Insights from Immunogenomics
4个月前
已完结
Rituximab for IgG4-related disease: a prospective, open-label trial
6个月前
已完结
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
6个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
7个月前
已完结
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
8个月前
已完结
皖公网安备34019202002308
